{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:13:23Z","timestamp":1789010003728,"version":"build-2803163510"},"reference-count":30,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:00:00Z","timestamp":1314921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1002\/ajh.22165","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T22:34:34Z","timestamp":1312497274000},"source":"Crossref","is-referenced-by-count":24,"title":["Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B\u2010ALL\/NHL 2002 protocol) in Burkitt's and primary mediastinal large B\u2010cell lymphoma"],"prefix":"10.1002","volume":"86","author":[{"given":"Michele","family":"Pohlen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans U.","family":"Gerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"Liersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Koschmieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf M.","family":"Mesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Appelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"M\u00fcller\u2010Tidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang E.","family":"Berdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,2]]},"reference":[{"key":"e_1_2_1_3_1_2_2","first-page":"8033","article-title":"Incorporation of rituximab and liposomal doxorubicin into CODOX\u2010m\/IVAC for HIV\u2010negative and HIV\u2010positive adult patients (pts) with untreated Burkitt's lymphoma (BL): Preliminary results of a multicenter phase II study","volume":"28","author":"Gregory SA","year":"2010","journal-title":"ASCO Meeting Abstracts"},{"key":"e_1_2_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21776"},{"key":"e_1_2_1_3_1_4_2","first-page":"2745","article-title":"Rituximab\u2010CHOP (R\u2010CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B\u2010Cell Lymphoma (PMLBCL)","volume":"108","author":"Vassilakopoulos TP","year":"2006","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.074"},{"key":"e_1_2_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn179"},{"key":"e_1_2_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0625-2"},{"key":"e_1_2_1_3_1_8_2","first-page":"929","article-title":"Primary mediastinal large B\u2010cell lymphoma (PMBL) outcome is significantly improved by the addition of rituximab to dose adjusted (DA)\u2010EPOCH and overcomes the need for radiation","volume":"106","author":"Dunleavy K","year":"2005","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_1_3_1_9_2","first-page":"4915","article-title":"Excellent results in the treatment of primary mediastinal lymphomas","volume":"116","author":"Schneider T","year":"2010","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq418"},{"key":"e_1_2_1_3_1_11_2","first-page":"518","article-title":"High survival rate in adult Burkitt's lymphoma\/leukemia and diffuse large B\u2010cell lymphoma with mediastinal involvement","volume":"110","author":"Hoelzer D","year":"2007","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-145128"},{"key":"e_1_2_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20143"},{"key":"e_1_2_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601460"},{"key":"e_1_2_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj030"},{"key":"e_1_2_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.2.429"},{"key":"e_1_2_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq015"},{"key":"e_1_2_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3181a34552"},{"key":"e_1_2_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2479"},{"key":"e_1_2_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl327"},{"key":"e_1_2_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh013"},{"key":"e_1_2_1_3_1_22_2","first-page":"3595","article-title":"Rituximab added to CODOX\u2010M\/IVAC is highly effective in HIV\u2010negative and HIV\u2010positive Burkitt lymphoma","volume":"112","author":"Abramson JS","year":"2008","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_1_3_1_23_2","first-page":"1781","article-title":"Long\u2010term outcome for de novo or minimally treated Burkitt\u2010type lymphoma\/leukemia (BL\/B\u2010ALL) after therapy with hyper\u2010CVAD and rituximab","volume":"116","author":"Thomas DA","year":"2010","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.060"},{"key":"e_1_2_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2006.02.001"},{"key":"e_1_2_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2461"},{"key":"e_1_2_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.9.2465"},{"key":"e_1_2_1_3_1_28_2","first-page":"858","article-title":"Efficacy and toxicity of rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or Burkitt\u2010like leukemia\/lymphoma: Cancer and Leukemia Group B (Calgb) Study 10002","volume":"116","author":"Rizzieri DA","year":"2010","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2006.01258.x"},{"key":"e_1_2_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6"},{"key":"e_1_2_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.22165","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.22165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T15:52:47Z","timestamp":1700581967000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.22165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,2]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1002\/ajh.22165"],"URL":"https:\/\/doi.org\/10.1002\/ajh.22165","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,2]]}}}